Manbearpig2097
Posted - 1 day ago
$IKT I’m in
QuizNose
Posted - 1 day ago
$IKT this is just hilarious — data must be close
BiotechJedi1728
Posted - 1 day ago
$IKT Run my child. Your time has come.
QuizNose
Posted - 1 day ago
$IKT oh, so they’re starting to let this trend up again… ok lol
HuntingBenjmins
Posted - 1 day ago
$IKT DANGIT! Missed that $1.75. I’m guessing a good bounce from here.
jemer
Posted - 2 days ago
$IKT 11 Healthcare institutions which now own 55MM shares could buy up the 4MM outstanding shares in a heartbeat, if they so wished. Surprised that an entity is manipulating IKT's share price recently. Seems awfully dangerous to me. Also, don't see Werner releasing Parkinsons results on a Friday or on a holiday week. My bet is 1st week of December, especially if results are positive.
BiotechJedi1728
Posted - 2 days ago
$IKT Bought more at 1.95. Just missed 1.85. Shot up before I could snatch that bottom. Pretty happy with my share count now. This thing pops to $10-$20 on PD news. Enough for a down-payment on a car if I sell half. 🤞🏼 not a Lambo. Just something for my kid to drive.
G101SPM
Posted - 2 days ago
$IKT $1.85 bid. BUY/2X ADD TO LONG POSITION carries improved SPM on improved probability "... to advance IkT-001Pro into a late-stage clinical trial in Pulmonary Arterial Hypertension (PAH),” said Dr. Milton Werner, President and Chief Executive of Inhibikase. “This investment, with top tier dedicated healthcare investment funds, recognized the potential of IkT-001Pro to improve the lives of patients afflicted with PAH. We believe IkT-001Pro, a prodrug of imatinib, has the potential to ameliorate the safety and tolerability profile that precluded approval of imatinib for the treatment of PAH more than 10 years ago. This investment further validates the Company’s innovative approach to the development of kinase inhibitor therapeutics in the non-oncology setting." DAC (dollar average cost) (4) $1.985. EXIT $6.00 (near term as first tier).
jemer
Posted - 2 days ago
$IKT "Participant experience in the trial appears to be positive, as clinician and patient impression of disease status or severity is not changing over the 12 week course of dosing." Milton Werner March 7, 2024
Texastea666
Posted - 2 days ago
@BiotechJedi1728 I don't know why you think $IKT is an automatic Parkinson win?
penny_bagz
Posted - 2 days ago
$IKT picked up more probably bad idea catching this falling knife. Be back next week for another 100
BiotechJedi1728
Posted - 2 days ago
$IKT How long til Parkinson's announcement? Early next week? Who is selling now? Oh. Manipulators. MM's. Really a coin flip to double down here. I believe in the science. I don't believe in WallSt. morons and greedy fxcks.
HuntingBenjmins
Posted - 3 days ago
$IKT Dirty dog shorts…We had a good support at $1.92. They cracked it.
El_Tropical
Posted - 4 days ago
$IKT Increase authorized shares to 500m? WTF?
Stttttt
Posted - 4 days ago
$ADGM $DRUG $ENSC $IKT when ? $AZI is moving better then this
Timmyturner22
Posted - 4 days ago
$ADGM Double bottom. Re-break over $3.00 will start the next leg. Extreme high chance this stock sees a LARGE price target upgrade in the near future. Most likely the people who filed the 13G will pay analysts. This stock is so light, when they decide to send it, it will move dollars fast $DRUG $ENSC $IKT
biospeculator
Posted - 4 days ago
$IKT Two filings yesterday may account for recent pps weakness. GLTA
GuruChartist
Posted - 6 days ago
$IKT Is the trend broken?
BigPlaySnipers
Posted - 1 week ago
$ADGM Look at this weekly Mac-d + the massive 13g and tiny float. This can go big $ENSC $ATHA $DRUG $IKT
jemer
Posted - 1 week ago
$IKT Armistice is a nasty predatory hedge fund. Werner has been forced to take their offering $$$ in the past and Armistice has not been a "friend" to IKT. They pump up share price and sell their shares and then short against their warrants. Wouldn't surprise me if Armistice is manipulating share price down in anticipation of positive Parkinsons data. With 93% of shares now held by partnering institutions, anybody shorting IKT is playing with fire!
HuntingBenjmins
Posted - 1 week ago
$IKT When you see a 50% haircut to recent highs it makes you think that the big boys are privy to information we are not. SMH
HuntingBenjmins
Posted - 1 week ago
$IKT Wasn’t expecting it to actually get worst than yesterday!
wat92098
Posted - 1 week ago
$IKT buying all the way down
kneehighnigel
Posted - 1 week ago
$IKT is the trial news delayed. I only ever remember seeing (from $IKT ) "4th quarter 2024". I commented on here that midnight 31 December 2024 wouldn't be late. But somehow a legend has built around November. What was the source?
biospeculator
Posted - 1 week ago
$IKT With special thanks to TJC and his post of the fireside chat with Milton Werner and Maxim we can imo conclude he knows the unblinded results of the phase II study for PD. So why an apparent delay. IMO, always follow the money. If the results are good then he states every intention to raise capital for phase III. The phase IIb trial for PAH he believes is fully funded with the first raise. So why wait? Jan 3 special meeting in order to raise capital and maybe more important to grant additional shares to himself. For me I view this as a positive and will be a buyer during any additional weakness. JFK Jr is nothing but smoke or a buying opportunity for myself. We all remember Hillary's claims years ago and bought weakness and made $$$$. Also the recent buy rating now given twice is a clue. Companies never want to screw the analysts or investment banks they rely on. GLTA
wat92098
Posted - 1 week ago
Inhibikase Therapeutics’ $IKT
Promising Developments and Financial Backing Justify Buy Rating - TipRanks.com https://www.tipranks.com/news/blurbs/inhibikase-therapeutics-promising-developments-and-financial-backing-justify-buy-rating
Paper_Route_Frank
Posted - 1 week ago
$IKT accumulating @1.90
penfly
Posted - 1 week ago
$IKT so the news is delayed until maybe 2025?? Won't this price of 2.30 be a selling point for most people? Trial results could be negative and pushed back indefinitely..